Equity analyst research on UK stocks from DirectorsTalk

Five UK Stocks to Watch in 2024
[shareaholic app="share_buttons" id_name="post_below_content"]

DirectorsTalk brings you professional opinions from leading equity research analysts on companies listed on the London Stock Exchange. This article contains a small selection of five stocks in the clean energy, financial services and telecommunications sectors. Equity analyst research across all sectors is available here. DirectorsTalk aims to help investors make more informed investment decisions.

Quadrise plc (LON:QED) produce transition fuels called MSAR® (pronounced ‘em-sar’) and bioMSAR™, which allow clients in the shipping, utilities and industrial sectors to reduce carbon emissions whilst also saving costs.

Arbuthnot Banking Group PLC (LON:ARBB), trading as Arbuthnot Latham, provides private and commercial banking products and services in the United Kingdom.

TEAM plc (LON:TEAM) is building a wealth, asset management and complementary financial services group. 

Cerillion plc (LON:CER) is a leading provider of billing, charging and customer management systems with more than 20 years’ experience delivering its solutions across a broad range of industries including the telecommunications, finance, utilities and transportation sectors.

Tern PLC (LON:TERN) is an AIM-listed provider of venture capital to exciting IoT innovators seeking scale and market share.

Share on:
Find more news, interviews, share price & company profile here for:

If our articles help you then why not add us as a preferred news source on Google.

Quadrise and Licella tighten development plan for marine biofuel

Quadrise and Licella have set a clearer testing schedule for bio-oil marine fuels, with final laboratory work planned for the second half of 2026.

Markets face a new test from rates, oil and AI valuations

Markets enter the second half of 2026 facing higher rate expectations, renewed oil risks and a tougher test for AI-related valuations.

Talking Medicines highlights strategic value of patient journey intelligence

Patient journey intelligence can help healthcare organisations identify care barriers and design more responsive pathways around real patient experiences.

Cerillion addresses telecoms transformation priorities for 2026

Cerillion joins TM Forum to examine how telecoms operators are resetting their IT transformation priorities for 2026 as AI adoption develops.

Arbuthnot Banking Group Plc 1H’26: accelerating franchise growth

Arbuthnot Banking Group delivered broad-based growth across deposits, specialist lending and wealth management in 1H’26, achieving its £10bn client balances target two years early. Despite pressure from lower interest rates, the bank remains well capitalised, offers a dividend yield of around 7%, and trades at a substantial discount to NAV.

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Search

Search